CONTACT: Maria Enie menie@vancomm.com or 202-248-5454 New Research Finds Treatment Advancements Helped Substantially Reduce Mortality Rates from Unruptured Brain Aneurysms in Past Decade FAIRFAX, Va. — Mortality rates after treatment of unruptured intracranial aneurysms have substantially decreased in the past decade, according to new findings presented today at the Society of NeuroInterventional Surgery’s (SNIS) 17th […]
COVID-19, Racial Disparities and Stroke Triage Among New Research Topics to be Discussed at Society of NeuroInterventional Surgery’s 17th Annual Meeting
FOR IMMEDIATE RELEASE: July 31, 2020 CONTACT: Maria Enie, menie@vancomm.com or 202-248-5454 COVID-19, Racial Disparities and Stroke Triage Among New Research Topics to be Discussed at Society of NeuroInterventional Surgery’s 17th Annual Meeting FAIRFAX, Va. — The next frontier in neurointerventional surgery, including advances in stroke triage and management, innovations in artificial intelligence and robotics […]
Joint Statement from the AANS/CNS, SNIS & SVIN
The AANS/CNS Joint Cerebrovascular Section, the Society of NeuroInterventional Surgery (SNIS) and the Society of Vascular & Interventional Neurology (SVIN) have issued a statement on unacceptable health care disparities in our nation. You can read the statement in its entirety here. […]
Care Recommendations for Emergent Neurointerventional Patients in the Setting of COVID-19
SNIS has developed a set of care recommendations for neurointerventional physicians that cover management of stroke thrombectomy with an emphasis on safety measures for health care providers. The recommendations include guidance for treating patients who are COVID-positive, COVID-negative, or COVID-undocumented. As the COVID-19 pandemic continues to unfold, SNIS will consider revisiting their recommendations if needed […]
MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms
MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms. The FRED® device is the first flow diverter in the U.S. to use a self-expanding braided nitinol mesh to help re-direct blood […]
